LUNG CANCER RESEARCH FOUNDATION logo

LCRF | Bayer Research Award on Innovative Therapeutic Strategies to Treat Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations

LUNG CANCER RESEARCH FOUNDATION

Funding Amount

Varies

Deadline

Rolling / Open

Grant Type

foundation

Overview

LCRF | Bayer Research Award on Innovative Therapeutic Strategies to Treat Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations

Funder: Lung Cancer Research Foundation (LCRF) and Bayer
Geographic Scope: International (scientists around the world)
Focus Areas: Innovative therapeutic strategies for HER2-mutated and HER2-altered lung cancers

Description

Annual research award supporting innovative therapeutic approaches for treating lung cancers with HER2 mutations and/or other HER2 alterations. Recipients are selected from hundreds of applicants.

Eligibility

Open to scientists, physicians, students, and fellows working on HER2-related lung cancer research.

    Contact

  • Phone: (212) 588-1580
  • Email: info@LCRF.org
  • Mailing Address: PO Box 780990, Philadelphia, PA 19178-0990

Focus Areas & Funding Uses

Fields of Work

cancerscience-research

Categories

Browse similar grants by category

Related Grants

Similar grants from this funder and related organizations

Ready to apply for LCRF | Bayer Research Award on Innovative Therapeutic Strategies to Treat Lung Cancers Harboring HER2 Mutations and/or Other HER2 Alterations?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.